Prospective Evaluation of the Efficacy of Palivizumab Administration in Children Born at 29-32 Weeks of Gestation

Conditions

• Bronchial Hyperreactivity
• Infant, Premature

Interventions

• OTHER: Methacholine Challenge Test (MCT)
• OTHER: Monthly telephone contact
• OTHER: Visits to the study site
• OTHER: Blood Test
• OTHER: Fractional exhaled nitric oxide

Sponsor

Rambam Health Care Campus